Diego Lucero - Concepedia

Author

Diego Lucero

Universidad de Buenos Aires ORCID

Also Known As

D Lucero, D. Lucero, D.M. Lucero, Diego Alejandro Salinas Lucero, Diego Lucero, Don Eliseo Lucero, Lucero, D.

Publications

662

Citations

H-Index

Concepts

All Affiliations

Universidad de Buenos Aires National Heart Lung and Blood Institute National Institutes of Health Hospital Muñiz Hospital Posadas

About

Diego Lucero is an author at Universidad de Buenos Aires specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	250
2	Health Sciences	7	7	190
3	Biochemistry	2	2	50
4	Diabetes	2	2	57
5	Cell Biology	1	1	31

Diego Lucero

Publications

603

Citations

H-Index

Page 1

	Year	Citations
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test Maureen Sampson, Anna Wolska, Russell Warnick, Clinical Chemistry	2021	85
New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans María Eugenia Inzaugarat, Elena De Matteo, Plácida Baz, PLoS ONE	2017	65
Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance Verónica Miksztowicz, Diego Lucero, Valeria Zago, Diabetes/Metabolism Research and Reviews	2012	49
Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins Diego Lucero, Verónica Miksztowicz, Gisela Gualano, Clinica Chimica Acta ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2017	38
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome Diego Lucero, Valeria Zago, Graciela López, Clinica Chimica Acta Metabolic DisorderPathologyFatty Liver DiseaseObesityMetabolic Syndrome	2010	36
Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT Diego Lucero, Denis Sviridov, Lita A. Freeman, Atherosclerosis ObesityMetabolic SyndromeMetabolic DisorderCardiovascular DiseasePhysiology	2015	35
Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine Gabriela Brenta, Gabriela Berg, Verónica Miksztowicz, Thyroid	2016	35
Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome? Diego Lucero, Valeria Zago, Graciela López, Clinica Chimica Acta Metabolic DisorderNon-alcoholic FattyFatty Liver DiseaseObesityMetabolic Syndrome	2010	33
Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis Diego Lucero, Promotto Islam, Lita A. Freeman, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids InflammationMacrophage BiologyCytokineMedicineFluid-phase Endocytosis	2019	31
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography Diego Lucero, Valeria Zago, Gustavo H. López, Clinical Biochemistry Metabolic SyndromeMetabolic DisorderBiochemistryMedicineLarge Vldl Particles	2012	29

Page 1